Sickle cell hepatopathy: Clinical presentation, treatment, and outcome in pediatric and adult patients

Hyunah Ahn, Chin-Shang Li, Winfred Wang

Research output: Contribution to journalArticle

69 Citations (Scopus)

Abstract

Background. Standard diagnostic criteria and therapy are lacking for sickle cell hepatopathy, an uncommon complication of sickle cell disease. Here we propose diagnostic and therapeutic guidelines based on our experience and on reported cases. Methods. We defined sickle hepatopathy by a total serum bilirubin concentration >13 mg/dl not explained by severe acute hemolysis, viral hepatitis, extrahepatic obstruction, or hepatic sequestration. We reviewed the records of all children with sickle hepatopathy seen at our institution during the past 20 years and the reported cases from the literature. Patients were categorized into two groups based on whether hepatic dysfunction at presentation was mild (Group I) or severe (Group II). Results. Seven patients were identified from our institution and 37 patients from the literature. The 44 patients were evenly divided between the two groups. Group I patients had a significantly lower mean age (11.8 years vs. 24.5 years, P=0.0001), maximum bilirubin level (36.2 mg/dl vs. 76.8 mg/dl, P=0.0008), and frequency of treatment with exchange transfusions (P=0.03). Overall, mortality was 4% in Group I and 64% in Group II (P=0.0001). Gender and recurrence rate did not differ. Among Group II patients, only two of nine who received exchange transfusion died, whereas 12 of 13 who did not receive exchange transfusion died (P=0.0015). Conclusions. Sickle cell hepatopathy is an uncommon complication characterized by extreme hyperbilirubinemia and either mild or severe hepatic dysfunction. Children and adults can present with either form; however, adults have a higher frequency of the severe form. Exchange transfusion may be the only effective management for initial episodes of severe sickle cell hepatopathy.

Original languageEnglish (US)
Pages (from-to)184-190
Number of pages7
JournalPediatric Blood and Cancer
Volume45
Issue number2
DOIs
StatePublished - Aug 2005
Externally publishedYes

Fingerprint

Pediatrics
Bilirubin
Liver
Hyperbilirubinemia
Sickle Cell Anemia
Hemolysis
Hepatitis
Therapeutics
Guidelines
Recurrence
Mortality
Serum

Keywords

  • Hepatopathy
  • Hyperbilirubinemia
  • Sickle cell disease

ASJC Scopus subject areas

  • Cancer Research
  • Pediatrics, Perinatology, and Child Health
  • Hematology

Cite this

Sickle cell hepatopathy : Clinical presentation, treatment, and outcome in pediatric and adult patients. / Ahn, Hyunah; Li, Chin-Shang; Wang, Winfred.

In: Pediatric Blood and Cancer, Vol. 45, No. 2, 08.2005, p. 184-190.

Research output: Contribution to journalArticle

@article{ce624ec5aa024ea0a501c5a1cb8e8514,
title = "Sickle cell hepatopathy: Clinical presentation, treatment, and outcome in pediatric and adult patients",
abstract = "Background. Standard diagnostic criteria and therapy are lacking for sickle cell hepatopathy, an uncommon complication of sickle cell disease. Here we propose diagnostic and therapeutic guidelines based on our experience and on reported cases. Methods. We defined sickle hepatopathy by a total serum bilirubin concentration >13 mg/dl not explained by severe acute hemolysis, viral hepatitis, extrahepatic obstruction, or hepatic sequestration. We reviewed the records of all children with sickle hepatopathy seen at our institution during the past 20 years and the reported cases from the literature. Patients were categorized into two groups based on whether hepatic dysfunction at presentation was mild (Group I) or severe (Group II). Results. Seven patients were identified from our institution and 37 patients from the literature. The 44 patients were evenly divided between the two groups. Group I patients had a significantly lower mean age (11.8 years vs. 24.5 years, P=0.0001), maximum bilirubin level (36.2 mg/dl vs. 76.8 mg/dl, P=0.0008), and frequency of treatment with exchange transfusions (P=0.03). Overall, mortality was 4{\%} in Group I and 64{\%} in Group II (P=0.0001). Gender and recurrence rate did not differ. Among Group II patients, only two of nine who received exchange transfusion died, whereas 12 of 13 who did not receive exchange transfusion died (P=0.0015). Conclusions. Sickle cell hepatopathy is an uncommon complication characterized by extreme hyperbilirubinemia and either mild or severe hepatic dysfunction. Children and adults can present with either form; however, adults have a higher frequency of the severe form. Exchange transfusion may be the only effective management for initial episodes of severe sickle cell hepatopathy.",
keywords = "Hepatopathy, Hyperbilirubinemia, Sickle cell disease",
author = "Hyunah Ahn and Chin-Shang Li and Winfred Wang",
year = "2005",
month = "8",
doi = "10.1002/pbc.20317",
language = "English (US)",
volume = "45",
pages = "184--190",
journal = "Pediatric Blood and Cancer",
issn = "1545-5009",
publisher = "Wiley-Liss Inc.",
number = "2",

}

TY - JOUR

T1 - Sickle cell hepatopathy

T2 - Clinical presentation, treatment, and outcome in pediatric and adult patients

AU - Ahn, Hyunah

AU - Li, Chin-Shang

AU - Wang, Winfred

PY - 2005/8

Y1 - 2005/8

N2 - Background. Standard diagnostic criteria and therapy are lacking for sickle cell hepatopathy, an uncommon complication of sickle cell disease. Here we propose diagnostic and therapeutic guidelines based on our experience and on reported cases. Methods. We defined sickle hepatopathy by a total serum bilirubin concentration >13 mg/dl not explained by severe acute hemolysis, viral hepatitis, extrahepatic obstruction, or hepatic sequestration. We reviewed the records of all children with sickle hepatopathy seen at our institution during the past 20 years and the reported cases from the literature. Patients were categorized into two groups based on whether hepatic dysfunction at presentation was mild (Group I) or severe (Group II). Results. Seven patients were identified from our institution and 37 patients from the literature. The 44 patients were evenly divided between the two groups. Group I patients had a significantly lower mean age (11.8 years vs. 24.5 years, P=0.0001), maximum bilirubin level (36.2 mg/dl vs. 76.8 mg/dl, P=0.0008), and frequency of treatment with exchange transfusions (P=0.03). Overall, mortality was 4% in Group I and 64% in Group II (P=0.0001). Gender and recurrence rate did not differ. Among Group II patients, only two of nine who received exchange transfusion died, whereas 12 of 13 who did not receive exchange transfusion died (P=0.0015). Conclusions. Sickle cell hepatopathy is an uncommon complication characterized by extreme hyperbilirubinemia and either mild or severe hepatic dysfunction. Children and adults can present with either form; however, adults have a higher frequency of the severe form. Exchange transfusion may be the only effective management for initial episodes of severe sickle cell hepatopathy.

AB - Background. Standard diagnostic criteria and therapy are lacking for sickle cell hepatopathy, an uncommon complication of sickle cell disease. Here we propose diagnostic and therapeutic guidelines based on our experience and on reported cases. Methods. We defined sickle hepatopathy by a total serum bilirubin concentration >13 mg/dl not explained by severe acute hemolysis, viral hepatitis, extrahepatic obstruction, or hepatic sequestration. We reviewed the records of all children with sickle hepatopathy seen at our institution during the past 20 years and the reported cases from the literature. Patients were categorized into two groups based on whether hepatic dysfunction at presentation was mild (Group I) or severe (Group II). Results. Seven patients were identified from our institution and 37 patients from the literature. The 44 patients were evenly divided between the two groups. Group I patients had a significantly lower mean age (11.8 years vs. 24.5 years, P=0.0001), maximum bilirubin level (36.2 mg/dl vs. 76.8 mg/dl, P=0.0008), and frequency of treatment with exchange transfusions (P=0.03). Overall, mortality was 4% in Group I and 64% in Group II (P=0.0001). Gender and recurrence rate did not differ. Among Group II patients, only two of nine who received exchange transfusion died, whereas 12 of 13 who did not receive exchange transfusion died (P=0.0015). Conclusions. Sickle cell hepatopathy is an uncommon complication characterized by extreme hyperbilirubinemia and either mild or severe hepatic dysfunction. Children and adults can present with either form; however, adults have a higher frequency of the severe form. Exchange transfusion may be the only effective management for initial episodes of severe sickle cell hepatopathy.

KW - Hepatopathy

KW - Hyperbilirubinemia

KW - Sickle cell disease

UR - http://www.scopus.com/inward/record.url?scp=22244448421&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=22244448421&partnerID=8YFLogxK

U2 - 10.1002/pbc.20317

DO - 10.1002/pbc.20317

M3 - Article

C2 - 15747337

AN - SCOPUS:22244448421

VL - 45

SP - 184

EP - 190

JO - Pediatric Blood and Cancer

JF - Pediatric Blood and Cancer

SN - 1545-5009

IS - 2

ER -